Introduction m -D iam inedichloroplatinum (II) and related compounds are antitum or agents, and some are used clinically in the treatm ent of several types of cancer [2] , but their toxicity and lack of selectivity is an obstacle in chemotherapy. Some cancers hav ing a high concentration of receptors for steroidal hormones, respond to horm onal treatm ent [3] . This fact stimulated the search for the possibility of using hormones as carriers of m ustards [4] and nitrosoureas [5] . Since the introduction of organometallic complexes into metalloimm unoassay [6] many horm one-bound Pt(II) and Pd(II) complexes have been prepared in the hope to achieve a selec tive transport into cancerous cells and thereby to lower their toxicity [7] . This approach has also been applied to non-steroidal estrogen-receptor binding molecules, as has been reported by Schö nenberger and coworkers in a series o f papers [8] . Hormones bound to transition metal carbonyls have been studied as m arkers for estrogen or p ro gesterone receptors [9] . Some complexes have been prepared for high field N M R and X-ray crystallographic studies [10] . M any c/s-Pt(II) complexes of a O n leave from the D ep artm en t o f B iophysics, Weizm ann Institute o f Science, R eho v o t, Israel.
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Verlag der Zeitschrift für N aturforschung, D-7400 Tübingen 0932-0776/90/0600-0817/S 01.00/0 a-am ino acids and their derivatives have been pre pared [11, 12] and tested for ««//-tumor activity [11, 13] . O ur group has shown that platinum (II) is an effective amino protecting group for reactions at coordinated a-amino acids and at a-am ino acid derivatives [11, 12] . /-Butylamine has been intro duced into platinum(II) compounds of a-amino acids in order to increase liposolubility [14] , In the present work amino functionalized es trone, estradiol and estrane have been bound as amides to platinum coordinated glycine. U nm odi fied estrone, prednisone, prednisolone and testos terone have been used as alcoholic groups to pre pare am ino acid esters as ligands o f platinum(II) and palladium (II) complexes. The facility of amide bond form ation with platinum -bound amino acids or di-or tripeptides may find applications in heavy metal labelling of biomolecules.
Results and Discussion
Estradiol-and estrone-3-(2-aminoethoxy)ethers 4, 5 have been prepared by etherification o f the parent horm ones with N-2-bromoethyl-/-butyl carbam ate (2), followed by removal of Boc with m ethanolic HC1 (see Scheme 1) . This m ethod has an advantage over etherification with chloroacetonitrile, followed by LiAlH4 reduction [15] , since it can also be applied to estrone derivatives. The carbam ate 2 was obtained in 90% yield by controlled acylation of 2-bromoethylamine and
chrom atographic purification, as compared with 8% yield reported earlier [16] .
The synthesis of 17-a-aminomethylestradiol (9)
proceeded through the cyanohydrin silyl ether (7) (see Scheme 2) according to similar functionalization procedures reported earlier [17] . The amine 8 obtained by LiAlH4 reduction exhibits in its N M R spectrum an AB quartet of prochiral methylene protons at 2.58 and 2.98 ppm, indicating that no rearrangem ent of the five-membered ring occurred during the reduction procedure. The silylated ether 8 is m ore soluble in organic solvents than the un protected ether 9, and easily undergoes coupling reactions. The facile removal of the r-BuMe2Si-group with [«-Bu]4N F renders it more suitable as a protecting group in organometallic and coordina tion com pounds [18, 9 a] than benzyl ether which was previously used in the synthesis of 9 [5] . The amine 10 was prepared by sodium reduction of es trone oxime [19] . According to its N M R spectrum 10 contains a small satellite at 0.64 ppm, in addi-
tion to the methyl signal at 0.59 ppm pointing to the presence o f the a-isomer. M ethods for amide bond form ation between the free carboxylic group of P t-N -co o rd in ated amino acids and am ino acid esters [11, 12] give the complexes 14-23 (see Scheme 3).
Alternatively, 11 was transform ed into the acyl chloride complex 13 [12 h tions. To clarify this point /ra/w-derivatives 14 b, 17b and 18b, were also prepared. Trying to extend the acyl chloride activation m ethod to ester form ation with horm one-bearing hydroxyl group o f estrone, prednisone and prodnisolone, we obtained only the mono ester com pounds 24, 27 and 33 in the m -series. It appears that esterification is more sensitive to steric factors than am idation (see Scheme 4) .
Activation with phosphoric acid m onophenyl ester dichloride in D M F [20] , which proceeds through the O-acyl formimidium chloride or the mixed anhydride, is more efficient and leads to bis(ester) complexes 25, 28 and 31 in the transseries. By this m ethod the Pd(II) com pounds of histidine esters of estrone, prednisone, predniso lone and testosterone 26, 29, 32, 35 have also been prepared.
All complexes exhibit in their IR spectra ali phatic CH-bands of the steroidal skeleton at 2920 and 2860, and C = C absorptions at 1600 and 1490 cm "1, a (P t)-N H 2 bending band at 1565-1575 cm "1 and v P t-C l around 320 cm "1. The amides 1 4 -2 3 show amide I bands at 1655-1670, amide II bands in the 1530-1550 cm "1 region, and the esters 24-35 exhibit carbonyl bands at 1735 -1760 cm "1. All absorptions of the cis-series are broadened due to hydrogen bonding. In the transseries, where the glycine moiety is well separated by the steroidal skeleton from another function as in 14 b, well resolved bands in the NH-stretching and bending regions are observed, as well as a sharp v P t-C l absorption (see Table I ).
The ]H N M R spectra of all complexes exhibit the characteristic patterns of the parent hormones and a broad (M )-N H 2 signal at 5.7-5.8 ppm. The amides show the C O N H resonance at 8 -9 ppm. The AB quartet of C -21-methylene protons of prednisone and prednisolone at 4.3 and 4.6 ppm changes to a broad multiplet shifted to 4.9 ppm in the esters; the C -l8 methyl signal of testosterone is shifted down-field by 0.14 ppm.
Anti-Tumor tests ( carried out by H. Schönenberger and coworkers)
The c/s-dichlorobis(glycinamidohormone)platinum(II)-complexes 14a, 15a, 17a and 18a and the parent horm ones were subjected to preliminary anticancer evaluations in M DA-M B231 and T able I. A nalytical data for the new am ino-functionalized estrogens an d th eir complexes. M CF-7 cell lines. The breast carcinoma M CF-7 cells are known to possess estrogen and progester one receptors [21] . The growth inhibition was fol lowed by 3H thymidine incorporation (see Table  IV ). It appears that the complexes 14a and 15a, in 
Experimental
All reactions were performed in a nitrogen a t mosphere. All solvents were purified as described in the literature. Melting points were determined on a Mel-Temp apparature and are uncorrected. 'H N M R spectra were recorded on a Jeol FX 90 spectrometer in d6-DMSO solutions with tetramethylsilane as the internal standard. The full range IR spectra (4400-200 cm "1) were obtained with a Perkin-Elmer 325 spectrometer in KBr pel lets.
C ,H ,N analyses were performed by the Microanalytical Laboratory of the Inorganic Chemis try Institute of M unich University.
Carbamic acid-2-brom oethyl-t-butyl ester (2)
2-Bromoethylamine hydrobromide (14.35 g, 0.07 mol) was divided into 2 g portions. At inter vals of 5 min, each portion was neutralized with cold 1 M KOH (10 ml) in an ice bath and added to a precooled solution of di-/-butyl dicarbonate (12.9 g, 0.06 mol) in TH F (60 ml). The reaction mixture was stirred for 3 h at 0 °C, and overnight at room temperature. Hexane (100 ml) was added. The organic layer was separated, washed three times with water, dried (Na2S 0 4), concentrated and filtered through a S i0 2 column (Merck, 3 5 -7 0 mesh, 60 g) using 10% EtOAc-hexane as eluent, yielding 12 g (91 %) o f 2, m. p. 27 °C. In Lit. 
Analysis fo r C 7H ]4B rN 0 2
Calcd C 37.51 H 6.29 N 6.24, Found C 37.59 H 6.22 N 6.51.
Unlike the «-butyl analogue, 2 [22] undergoes slow decomposition at room temperature, but is stable when stored at -10 °C for several months.
E stra -l,3 ,5 (10)-trien-17ß-ol-3(2-ethoxy carbamic acid t-butyl ester) (3 a)
Sodium hydride in oil (380 mg, 55-60% ) was added in portions to a solution of estradiol (2,17 g, 8 mmol) in D M F (20 ml) and TH F (5 ml) and stirred for 3 h until H 2 evolution was complete. («-Bu)4N I (150 mg) was added, followed by dropwise addition of 2 (2.8 g, 0.0012 mol) in D M F (5 ml). The mixture was stirred for 24 h, poured into water (350 ml), and extracted with ethyl ace tate (2x150 ml). The organic layer was washed once with water, dried (N a2S 0 4) and concentrated to a volume of 50 ml. Neutral alumina (Fluka, type 507 C, 20 g) was added, the mixture well shaken, evaporated and loaded as an upper layer of a colum n previously filled with neutral alumina (30 g) in hexane. The oil was eluted with hexane, and 3 a obtained by elution with 25% EtOAc-hexane (2.3 g, 69%) and crystallization from CH 2C12. Rf = 0.41 (TLC on alumina 60 F 254 elution EtOAc-hexane 3:7, detection with UV or I2). C om pound 6, prepared according to a pub lished procedure [23] (2.3 g, 6 mmol) was added to trimethylsilyl cyanide (2 g, 0.02 mol), followed by Z n l2 (25 mg) . The starting com pound dissolved and, after 10 min, 7 precipitated. The excess of re agent was evaporated, the residue mixed with cold ethanol, filtered (2.55 g, 91%) and recrystallized from ethanol. N M R (CDC13): ö = 7.11 and 6.59 (AB q, 7 = 9 Hz, 2H , ArH); 6.55 (s, 1 H, ArH); 2.78 (m, 2H , benzylic); 1. The solution of crude 7 (3.5 g, 7.5 mmol) in ab solute ether (100 ml) was slowly added to a mix ture of LiAlH4 (2 g, 52 mmol) in ether (200 ml) and refluxed for 2 h. After cooling, cold water (40 ml) was added, followed by 10% N aO H (40 ml). The organic layer was separated, the water layer extracted with ether (2 x 150 ml), the com bined ether extract washed once with water, dried (N a2S 0 4) and concentrated. The residue recrystal lized from hexane (2. 4 g, 77%) . N M R (CDC13): S = 7.11 and 6.59 (AB q , 7 = 9 H z , 2 H, ArH); 6.53 (s, 1 H, ArH); 2.97 and 2.59 (AB q, J = 12 Hz, 2H , CH,N ); 2.77 (m, 2H , benzylic); 2 .3 -1.2 (m, CH-, and CH); 0.97 (s, 9H , C H 3); 0.93 (s, 3H , C H 3); 0.18 (s, 6H , SiCH3). Aminomethvlestr a -1,3,5 (10 ) -triene-3 ,17 ß-diol (9) C om pound 8 (0.83 g, 2 mmol) was dissolved in dry T H F (5 ml). After cooling a solution of («Bu)4N F (1.05 g, 0.03 mmol) in T H F (5 ml) was added. The mixture was stirred at 0 CC for 4 h and centrifuged. The T H F was discarded and the crys talline 9 filtered, washed 3 times with TH F, then with water, and recrystallized from methanol (515 mg, 85%), m .p. 254-256 °C, Lit. [4] 241 -242 °C.
a-
cis-Dichlorobis (glycine)platinum (II) (11a) C om pound 11a was prepared by slight modifi cation o f the published procedure [24] , To the mix ture o f K 2PtCl4 (4.8 g, 0. 0115 mol) and glycine (9 g, 0. 12 mol) in water (22 ml) , KOH (6.7 g, 0. 117 mol) was added in portions. The solution was heated at 90 °C bath tem perature for 6 h, and over night at 70 °C, cooled, and acidified with conc. HC1 to pH 3.5. The precipitated Pt(Gly)2(GlyH)2 was filtered, washed with cold water, dried and trans formed into m -P t(N ,0 -G ly )2 by heating for 2 h at bath tem perature 9 0 -9 5 °C in water suspension (15 ml) . At lower tem perature (80 °C) the form a tion of the chelate does not occur, and at a higher tem perature (105 °C) isomerization to the trans isomer with some decomposition is observed. The chelate c/s-P t(N ,0 -G ly )2 is transformed quantita tively into the m -P tC l2(GlyH)2 by stirring for 2 h at room tem perature with conc. HC1 (5 ml), fol lowed by evaporation in high vacuum at room temperature. The spectroscopic data are identical with those previously reported [25] .
cis-Dichloro (histidine)palladium ( II) (11 b) The complex l i b was prepared according to the published procedure [26] .
General procedures fo r the preparation o f cis-and tr ans-dich lor obis (glycinamide ) platinum ( II) complexes 14-23
M ethod A EDC (4.41 g, 2.2 mmol) is added in portions to a solution o f Cl2Pt(GlyH)2 (0.416 g, 1 mmol) and N-hydroxysuccinimide (0.23 g, 2 mmol) in dry D M F (10 ml) at -1 0 °C. The mixture is stirred at -1 0 °C for 1 h and at room temperature over night. The resulting yellow active-ester solution is filtered and added dropwise to a mixture of hor mone (2 mmol) and N E t3 (2 mmol), (4 mmol of N E t3 are used if the horm one is used as the hy drochloride) in D M F (10 ml) at 0 °C. Stirring is continued at 0 °C for 4 h, and at room tem pera ture overnight. The solvent is evaporated in high vacuum at 35 °C bath tem perature and the residue is triturated with water (10 ml) and centrifuged (5 times), triturated once with methanol, filtered and dried in high vacuum at about 40 °C for 24 h.
M ethod B
PtC l2(GlyCl)2 (453 mg, 1 mmol) [12h] is sus pended in T H F (8 ml) upon cooling in an ice bath, and the horm one (2 mmol) is added in one lot, fol lowed by dropwise addition of N E t3 (2 mmol); us ing 4, 4 mmol were added. The mixture is stirred for 2 h at 0 °C, and for 2 h at room temperature, the solvent is evaporated in high vacuum and the pale yellow residue triturated 5 times with water, filtered, washed with methanol and dried in high vacuum over P2Os. cis-Dichloro (glycine) (glycine-estrone ester) -platinum (II) (24) . The solvent is evaporated and the residue is triturated several times with EtOAc until no traces of free hormone are detected in TLC (Alumina, Merck F 60, elution with CHC13-EtOH 98:2), then triturated once with 0.02 M HC1 (25 ml) and dried in high vacuum.
cis-Dichlorobis
trans-Dichlor obis (glycine-estrone ester ) platinum (II) (25) . After evaporation of dichloromethane the residue is triturated successively with water (20 ml) and ethanol.
cis-Dichloro(glycine) (glycine-prednisone ester) -platinum (II) (27) . This complex separates as a crystalline com pound upon washing between the CH 2C12/H 20 phases. It is triturated with water (50 ml) and ethanol (10 ml).
cis-Dichloro (glycine) (glycine-prednisolone ester)platinum ( II) (31) is isolated as (25) .
M ethod B
Phosphoric acid m onophenyl ester dichloride (70 mg, 0.5 mmol) and D M F (55 mg, 1.5 mmol) are mixed in a Schlenck tube under N 2. The formed formimidium chloride is stirred for 5 min. Cooling with an ice bath is applied and successive ly C H 2C12 (5 ml), PtC l2(GlyOH)2 (0.2 mmol) or PdCl2(HisOH) (0.4 mmol) are added, followed after 5 min by horm one (0.8 mmol) and after 15 min by Et3N (2 mmol). The mixture is stirred for 4 h in an ice bath, then the organic layer is shaken with 0.1 M HC1 (3x4 ml) and twice with water. 
cis-Dichloro ( histidine-esters ) palladium ( II)
of estrone (26), prednisone (30), prednisolone (33) and testosterone (35) were purified by triturations with water followed by ethanol.
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